| Literature DB >> 35983388 |
Mohannad Al-Tarakji1, Ahmad Zarour1, Rajvir Singh1, Mohamed Said Ghali2,1.
Abstract
Background/objective Acute appendicitis (AA) is one of the most common surgical emergencies that require a proper diagnosis to avoid a negative outcome in the case of missed or delayed diagnosis. Our study aims to assess the diagnostic power of the Alvarado score and the prediction of the severity of acute appendicitis in correlation to intraoperative findings and the final histopathology (HP) result. Methods This retrospective study was applied to 1,303 patients with clinically proven acute appendicitis (AA) and available HP results. We correlated Alvarado score to the gold standard HP and intraoperative findings. We selected the cutoff point of Alvarado at 5 and 7 as they were the most frequent cutoff value mentioned in the literature and based on the ROC curve in this study to assess sensitivity, specificity, positive predictive value (PPV), and negative predictive value (NPV). Results The mean age of the study cohort is 33.3 ± 9.5 years, with a male predominance (75.8%). The negative appendectomy (NA) rate was 4%. The operative complication rate was 1.2%, and we recorded one mortality case (0.1%). The diagnostic evidence of AA was in 95.9% of cases. Alvarado score ≥ 7 presented sensitivity and specificity of 66.4% and 69.8%, respectively, with PPV of 98.1% and NPV of 8.1%, with an accuracy of 66.5%. For Alvarado score ≥ 5, the sensitivity was 91.2%, specificity was 22.6%, PPV was 96.5%, NPV was 9.8%, and accuracy was 88.4%. In addition, we demonstrated statistical significance between Alvarado risk stratification with HP and intraoperative grades (p = 0.001 each). Conclusion The Alvarado scoring system alone is not enough to diagnose AA with unsatisfactory sensitivity and specificity. However, it is a good indicator of the severity of AA that we can depend on to prioritize those patients waiting for surgery.Entities:
Keywords: acute appendicitis; alvarado score; histopathology (hp); negative appendectomy rate; severity of disease
Year: 2022 PMID: 35983388 PMCID: PMC9376215 DOI: 10.7759/cureus.26902
Source DB: PubMed Journal: Cureus ISSN: 2168-8184
Alvarado score.
Alvarado risk stratification: score 1-4, low probability of acute appendicitis; score 5-6, intermediate probability of acute appendicitis; score 7-10, high probability of acute appendicitis
| Alvarado components | Score points |
| Symptoms | |
| Migratory pain to the right iliac fossa | 1 |
| Anorexia | 1 |
| Nausea or vomiting | 1 |
| Signs | |
| Tenderness of the right iliac fossa | 2 |
| Rebound tenderness | 1 |
| Temperature more than 37.3°C | 1 |
| Laboratory | |
| Leukocytes above 10,000 per µL | 2 |
| Neutrophilic count > 75% | 1 |
Demographics, clinical vitals, and laboratory results in relation to Alvarado risk stratification and histopathology grades.
SD: standard deviation; IQR: interquartile range; BMI: body mass index; SBP: systolic blood pressure; DBP: diastolic blood pressure; WBC: white blood cells; Hb: hemoglobin; BUN: blood urea nitrogen; PH: potential of hydrogen; CRP: C-reactive protein, CT: computed tomography
| Alvarado | HP | p-value | ||||||||
| Variable (mean ± SD) | Group I (n = 121) | Group II (n = 336) | Group III (n = 846) | Grade 0 (n = 52) | Grade I (n = 1,198) | Grade II (n = 42) | Grade III (n = 11) | Total (n = 1,303) | Alvarado | HP |
| Age (years) | 34 ± 10 | 32 ± 8.8 | 32 ± 10 | 31.4 ± 9.9 | 32.3 ± 9.5 | 34.3 ± 10.6 | 33.5 ± 9.6 | 33.3 ± 9.5 | 0.12 | 0.50 |
| Hospital stay (days) (IQR) | 2 (1-2) | 1.5 (1-2) | 2 (1-2) | 2 (1-2) | 2 (1-2) | 3 (2-5) | 2 (1-2) | 2 (1-2) | 0.25 | 0.001 |
| Surgery waiting time (hours) | 25.6 ± 12 | 25.8 ± 13 | 24 ± 11 | 26.7 ± 14.8 | 24.5 ± 11 | 22.5 ± 11.3 | 29.3 ± 4.6 | 26.6 ± 11 | 0.001 | 0.15 |
| Duration of symptoms (days) | 2.6 ± 2.7 | 1.9 ± 1.5 | 1.7 ± 1.2 | 3.4 ± 3 | 1.7 ± 1.4 | 1.9 ± 1.1 | 2.4 ± 1.4 | 1.8 ± 1.5 | 0.001 | 0.001 |
| BMI | 26.3 ± 4.7 | 25.7 ± 4.7 | 25.2 ± 4.9 | 25.9 ± 5 | 25.4 ± 4.8 | 26.7 ± 6 | 27 ± 8 | 25 ± 5 | 0.02 | 0.16 |
| SBP (mmHg) | 122 ± 14 | 119 ± 12 | 120 ± 13 | 118 ± 14 | 120 ± 13 | 120 ± 16 | 115 ± 9 | 120 ± 13 | 0.15 | 0.60 |
| DBP (mmHg) | 74.4 ± 8.9 | 73 ± 10 | 72 ± 9 | 20.9 ± 8.8 | 72.6 ± 9.5 | 73 ± 10 | 71 ± 5 | 73 ± 9 | 0.08 | 0.59 |
| Pulse rate (beats/minutes) | 77 ± 13 | 78 ± 12.9 | 81 ± 13 | 79.9 ± 13.5 | 79.5 ± 13 | 86.7 ± 14.9 | 77.6 ± 11 | 80 ± 13 | 0.003 | 0.006 |
| Temperature (°Celsius) | 36.8 ± 0.4 | 36.8 ± 0.5 | 36.9 ± 0.6 | 36.8 ± 0.6 | 36.9 ± 0.5 | 37 ± 0.6 | 36.7 ± 0.6 | 36.9 ± 0.6 | 0.001 | 0.001 |
| Oxygen saturation | 99 ± 0.9 | 99 ± 0.8 | 99 ± 1.2 | 99 ± 0.8 | 99 ± 1 | 98 ± 2.9 | 99 ± 0.8 | 99 ± 1.1 | 0.57 | 0.002 |
| WBC (103/uL) | 8.2 ± 2.5 | 11.3 ± 4.3 | 15 ± 3.6 | 11.1 ± 4.5 | 13.4 ± 4.3 | 14.7 ± 5.3 | 12.4 ± 5 | 13.9 ± 4.3 | 0.001 | 0.001 |
| Neutrophil count (103/uL) | 5.3 ± 1.9 | 8.3 ± 4.1 | 12.4 ± 3.5 | 7.7 ± 4.5 | 10.7 ± 4.2 | 12.4 ± 5 | 9.2 ± 4.7 | 10.6 ± 4.3 | 0.001 | 0.001 |
| Lymphocyte count (103/uL) | 2.1 ± 0.9 | 2.1 ± 0.9 | 1.6 ± 0.9 | 2.3 ± 0.9 | 1.8 ± 1 | 1.3 ± 0.8 | 2.2 ± 1.4 | 1.8 ± 1 | 0.001 | 0.001 |
| Platelet count (103/uL) | 245 ± 58 | 251 ± 63 | 259 ± 64 | 273 ± 59 | 255 ± 62 | 236 ± 79 | 293 ± 82 | 255 ± 63 | 0.02 | 0.007 |
| Hb (gm/dL) | 14 ± 1.7 | 14.3 ± 1.9 | 14.4 ± 1.7 | 13.5 ± 1.9 | 14 ± 1.7 | 14.2 ± 2.3 | 14 ± 2.2 | 14.3 ± 1.7 | 0.02 | 0.003 |
| International normalized ratio (INR) | 1 ± 0.1 | 1.2 ± 0.1 | 1.1 ± 0.2 | 1.1 ± 0.2 | 1.1 ± 0.1 | 1.3 ± 0.3 | 0.9 ± 0.08 | 1.1 ± 0.2 | 0.09 | 0.001 |
| Serum creatinine (umol/L) | 73.7 ± 16.4 | 72.5 ± 17.6 | 73.8 ± 23.9 | 66.5 ± 19.2 | 74 ± 22 | 79 ± 21 | 64 ± 14 | 73.5 ± 21.8 | 0.64 | 0.02 |
| Serum BUN (umol/L) | 3.8 ± 1.2 | 3.9 ± 2.6 | 4 ± 2.7 | 3.9 ± 1.4 | 3.9 ± 2.4 | 4.9 ± 6.1 | 3.3 ± 0.4 | 3.9 ± 2.6 | 0.82 | 0.05 |
| pH | 7.8 ± 0.03 | 7.4 ± 0.04 | 7.4 ± 0.04 | 7.4 ± 0.03 | 7.6 ± 0.04 | 7.4 ± 0.05 | 7.4 ± 0.03 | 7.4 ± 0.04 | 0.008 | 0.50 |
| Base excess (mmol/L) | 1.2 ± 1.6 | 0.9 ± 1.5 | 1 ± 1.5 | 1.1 ± 1.5 | 0.99 ± 1.5 | 0.7 ± 2.2 | 1 ± 1.9 | 1 ± 1.5 | 0.41 | 0.77 |
| Serum CRP (mg/L) | 31 ± 33 | 42 ± 61 | 53 ± 75 | 34.3 ± 55.9 | 46.1 ± 67 | 130 ± 98 | 14 ± 15.6 | 49 ± 70 | 0.03 | 0.001 |
| Serum lactate | 1.6 ± 0.6 | 1.8 ± 0.8 | 2.1 ± 0.9 | 1.5 ± 0.7 | 2 ± 0.9 | 2.3 ± 0.9 | 1.8 ± 1.1 | 1.9 ± 0.9 | 0.001 | 0.002 |
| Serum albumin (gm/L) | 39 ± 3.7 | 38.9 ± 4.4 | 39.5 ± 4.2 | 38 ± 3.9 | 39 ± 4.0 | 37 ± 4.5 | 37 ± 3.9 | 39 ± 4.2 | 0.34 | 0.001 |
| Serum glucose (mmol/L) | 5.9 ± 2.1 | 5.8 ± 1.3 | 6.4 ± 2.1 | 5.7 ± 1.2 | 6.2 ± 2.0 | 6.8 ± 1.9 | 5.8 ± 0.8 | 6.2 ± 1.9 | 0.001 | 0.06 |
| Appendicular diameter (CT finding) | 10.7 ± 2.4 | 10.5 ± 2.6 | 10 ± 2.8 | 9.1 ± 1.9 | 8.7 ± 1.8 | 11 ± 2.6 | 13.6 ± 3.0 | 10 ± 2.8 | 0.001 | 0.001 |
| Alvarado score | 5.8 ± 1.7 | 7.1 ± 1.7 | 7.6 ± 1.5 | 6.6 ± 2.2 | 7 ± 1.7 | 0.001 | ||||
Demographics and radiological and clinical characteristics in relation to Alvarado risk stratification and histopathology grades.
HP: histopathology; DM: diabetes mellitus; HTN: hypertension; CAD: coronary artery disease, CKD: chronic kidney disease; AF: atrial fibrillation; WBC: white blood cells
| Alvarado | HP | p-value | ||||||||
| Variable (N (%)) | Group I (n = 121) | Group II (n = 336) | Group III (n = 846) | Grade 0 (n = 52) | Grade I (n = 1,198) | Grade II (n = 42) | Grade III (n = 11) | Total (n = 1,303) | Alvarado | HP |
| Gender (male) | 89 (73.6) | 250 (74.4) | 649 (76.7) | 27 (51.9) | 919 (76.8) | 35 (83.3) | 7 (63.6) | 988 (75.8) | 0.58 | 0.001 |
| Nationality | 0.96 | 0.02 | ||||||||
| Asian | 97 (80.2) | 268 (79.8) | 689 (81.4) | 47 (90.4) | 968 (80.9) | 34 (81) | 5 (45.5) | 1,054 (80.9) | ||
| African | 23 (19) | 64 (19) | 149 (17.6) | 4 (7.7) | 218 (18.2) | 7 (16.7) | 6 (54.5) | 236 (18.1) | ||
| Others | 1 (0.8) | 4 (1.2) | 8 (0.9) | 1 (1.9) | 11 (0.9) | 1 (2.4) | 0 (0) | 13 (1) | ||
| Migratory abdominal pain | 37 (30.6) | 180 (53.6) | 651 (77) | 24 (46.2) | 806 (67.3) | 30 (71.4) | 7 (63.6) | 868 (66.6) | 0.001 | 0.01 |
| Fever | 16 (13.2) | 45 (13.4) | 154 (18.2) | 11 (21.2) | 192 (16) | 10 (23.8) | 1 (9.1) | 215 (16.5) | 0.08 | 0.38 |
| Anorexia | 27 (22.3) | 152 (45.6) | 583 (68.9) | 29 (55.8) | 698 (58.3) | 28 (66.7) | 6 (54.6) | 762 (58.5) | 0.001 | 0.71 |
| Nausea | 37 (30.6) | 179 (53.3) | 670 (79.2) | 35 (67.3) | 810 (67.7) | 31 (73.8) | 9 (81.8) | 886 (68) | 0.001 | 064 |
| Vomiting | 25 (20.7) | 147 (43.8) | 581 (68.7) | 29 (55.8) | 687 (57.4) | 31 (73.8) | 5 (45.5) | 753 (57.8) | 0.001 | 0.15 |
| Change in bowel habits | 7 (5.8) | 26 (7.7) | 70 (8.3) | 9 (17.3) | 87 (7.3) | 5 (11.9) | 1 (9.1) | 103 (7.9) | 0.63 | 0.05 |
| Smoking | 10 (8.3) | 29 (8.6) | 70 (8.3) | 1 (1.9) | 101 (8.4) | 6 (14.3) | 1 (9.1) | 109 (8.5) | 0.98 | 0.19 |
| Alcohol consumption | 1 (0.8) | 2 (0.6) | 13 (1.5) | 0 (0) | 15 (1.3) | 1 (2.4) | 0 (0) | 16 (1.2) | 0.28 | 0.74 |
| DM | 7 (5.8) | 15 (4.5) | 42 (5) | 4 (7.7) | 58 (4.8) | 1 (2.4) | 1 (9.1) | 64 (4.9) | 0.84 | 0.60 |
| HTN | 10 (8.3) | 7 (2.1) | 44 (5.2) | 3 (5.8) | 51 (4.3) | 5 (11.9) | 2 (18.2) | 61 (4.7) | 0.10 | 0.02 |
| CAD | 1 (0.8) | 0 (0) | 3 (0.4) | 1 (1.9) | 2 (0.2) | 1 (2.4) | 0 (0) | 4 (0.3) | 0.34 | 0.01 |
| CKD | 1 (0.8) | 0 (0) | 3 (0.4) | 0 (0) | 3 (0.3) | 1 (2.4) | 0 (0) | 4 (0.3) | 0.34 | 0.10 |
| AF | 0 (0) | 0 (0) | 1 (0.1) | 0 (0) | 1 (0.1) | 0 (0) | 0 (0) | 1 (0.1) | 0.76 | 0.99 |
| Blood culture | 0 (0) | 6 (1.8) | 13 (1.5) | 1 (1.9) | 13 (1.1) | 5 (11.9) | 0 (0) | 19 (1.5) | 0.35 | 0.001 |
| Surgery approach (laparoscopy) | 115 (95) | 313 (93.2) | 743 (87.8) | 52 (100) | 1,072 (89.6) | 37 (88.1) | 9 (81.8) | 1,170 (89.9) | 0.003 | 0.08 |
| Conversion | 0 (0) | 3 (0.9) | 5 (0.6) | 1 (1.9) | 7 (0.6) | 0 (0) | 0 (0) | 8 (0.6) | 0.55 | 0.61 |
| Operative complication | 1 (0.8) | 5 (1.5) | 10 (1.2) | 0 (0) | 14 (1.2) | 2 (4.8) | 0 (0) | 16 (1.2) | 0.83 | 0.16 |
| Postoperative drain | 0 (0) | 15 (4.5) | 38 (4.5) | 0 (0) | 43 (3.6) | 10 (23.8) | 0 (0) | 53 (4.1) | 0.60 | 0.001 |
| Postoperative imaging | 3 (2.5) | 10 (3) | 37 (4.4) | 3 (5.8) | 39 (3.3) | 6 (14.3) | 2 (18.2) | 50 (3.8) | 0.38 | 0.001 |
| Readmission | 0 (0) | 3 (0.9) | 17 (2) | 1 (1.9) | 18 (1.5) | 1 (2.4) | 0 (0) | 20 (1.5) | 0.13 | 0.93 |
| Reoperation | 0 (0) | 0 (0) | 3 (0.4) | 0 (0) | 3 (0.3) | 0 (0) | 0 (0) | 3 (0.2) | 0.44 | 0.97 |
| Mortality | 0 (0) | 0 (0) | 1 (0.1) | 0 (0) | 1 (0.1) | 0 (0) | 0 (0) | 1 (0.1) | 0.76 | 0.99 |
| WBCs (10,000-15,000 103/uL) | 75 (62) | 186 (55.4) | 309 (36.6) | 42 (80.8) | 528 (92.6) | 0 (0) | 0 (0) | 570 (43.5) | 0.001 | 0.001 |
| WBCs (>15,000 103/uL) | 28 (23.1) | 80 (23.8) | 324 (38.3) | 2 (3.8) | 398 (33.2) | 32 (76.2) | 0 (0) | 432 (33.2) | 0.001 | 0.001 |
Figure 1ROC curve.
Diagonal segments are produced by ties.
Histopathology (HP) findings in association with Alvarado groups.
| Histopathology (HP) | Alvarado | p-value | |||
| N (%) | Group I (n = 121) | Group II (n = 336) | Group III (n = 846) | Total | 0.001 |
| Grade 0 | 12 (9.9) | 25 (7.4) | 15 (1.8) | 52 (4) | |
| Grade I | 108 (88.4) | 299 (89) | 791 (93.6) | 1,198 (92) | |
| Grade II | 1 (0.8) | 8 (2.4) | 33 (3.9) | 42 (3.2) | |
| Grade III | 1 (0.8) | 4 (1.2) | 6 (7.1) | 11 (0.8) | |
| Total | 122 (100) | 336 (100) | 845 (100) | 1,303 (100) | |
Operating room (OR) findings in relation to Alvarado groups.
| OR grades | Alvarado | p-value | |||
| Group I (n = 121) | Group II (n = 336) | Group III (n = 846) | Total | 0.001 | |
| OR grade 0 | 3 (2.5) | 11 (3.3) | 5 (0.6) | 19 (1.5) | |
| OR grade I | 100 (82.6) | 274 (81.6) | 628 (74.2) | 1,002 (77) | |
| OR grade II | 7 (5.8) | 27 (8.0) | 149 (17.6) | 183 (14) | |
| OR grade III | 0 (0) | 1 (0.3) | 4 (0.5) | 5 (0.4) | |
| OR grade IV | 11 (9.1) | 23 (6.8) | 60 (7.1) | 94 (7.1) | |
| Total | 121 (100) | 336 (100) | 846 (100) | 1,303 (100) | |